Genemed: An informatics hub for the coordination of next-generation sequencing studies that support precision oncology clinical trials

Cancer Informatics

Volumn 14, Issue , 2015, Pages 45-55

  Zhao, Yingdong ^a   Polley, Eric C ^a   Li, Ming Chung ^a   Lih, Chih Jian ^b   Palmisano, Alida ^a   Sims, David J ^b   Rubinstein, Lawrence V ^a   Conley, Barbara A ^a   Chen, Alice P ^a   Williams, P Mickey ^b   Kummar, Shivaani ^a   Doroshow, James H ^a   Simon, Richard M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

Clinical trial; GeneMed; Informatics system; MPACT; Next generation sequencing; Precision medicine

Indexed keywords

DNA;

ACCESS TO INFORMATION; ACCURACY; ADVANCED CANCER; ARTICLE; AUTOMATION; DNA DETERMINATION; GENEMED; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; INTERNET; MEDICAL INFORMATICS; MEDICAL INFORMATION SYSTEM; MOLECULARLY TARGETED THERAPY; MUTATIONAL ANALYSIS; NATIONAL HEALTH ORGANIZATION; NEXT GENERATION SEQUENCING; ONCOLOGY; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOLID TUMOR; SOMATIC MUTATION; TUMOR GENE;

EID: 84925357033     PISSN: None     EISSN: 11769351     Source Type: Journal    
DOI: 10.4137/CIN.S17282     Document Type: Article

References (16)

1. Rothberg JM, Hinz W, Rearick TM, et al. An integrated semiconductor device enabling non-optical genome sequencing. Nature. 2011;475:348–52.
2. Gargis AS, Kalman L, Berry MW, et al. Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol. 2012;30:1033–6.
3. Vogelstein B, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science. 2013;339:1546–58.
4. Doroshow JH. Selecting systemic cancer therapy one patient at a time: is there a role for molecular profiling of individual patients with advanced solid tumors? J Clin Oncol. 2010;28(33):4869–71.
5. Simon R, Roychowdhury S. Implementing personalized cancer genomics in clinical trials. Nat Rev Drug Discov. 2013;12(5):358–69.
6. Simon R, Polley E. Clinical trials for precision oncology using next-generation sequencing. J Pers Med. 2013;10:485–95.
7. Tran B, Brown AM, Bedard PL, et al. Feasibility of real time next generation sequencing of cancer genes linked to drug response: results from a clinical trial. Int J Cancer. 2013;132(7):1547–55.
8. Kummar S, Williams PM, Lih CJ, et al. Application of molecular profiling in clinical trials for advanced metastatic cancers. J Natl Cancer Inst. 2015; 107(4):djv003.
9. Lih CJ, Sims DJ, Harrington RD, et al. Analytical Validation and Application of a Targeted Next Generation Sequencing Mutation Detection Assay for use in Treatment Assignment in a Cancer Clinical Trial (NCT01827384) submitted.
10. Bamford S, Dawson E, Forbes S, et al. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer. 2004;91(2):355–8.
11. Cingolani P, Platts A, Wang le L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso−3. Fly (Austin). 2012;6(2):80–92.
12. Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 2001;11(5):863–74.
13. Stenson PD, Ball EV, Mort M, Phillips AD, Shaw K, Cooper DN. The human gene mutation database (HGMD) and its exploitation in the fields of personalized genomics and molecular evolution. Curr Protoc Bioinformatics. 2012; Chapter 1:Unit1.13.
14. Sharma MK, Phillips J, Agarwal S, et al. Clinical genomicist workstation. AMIA Joint Summits Transl Sci Proc. 2013;2013:156–7.
15. Roy S, Burso MB, Wald A, Nikiforov YE, Nikiforova MN. SeqReporter: automating next-generation sequencing result interpretation and reporting workflow in a clinical Laboratory. J Mol Diagn. 2014;16:11–22.
16. Servant N, Roméjon J, Gestraud P, et al. Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial. Front Genet. 2014;5:152.